Impact of Copay Accumulator Legislation and IRA Changes to the Medicare Part D Benefit Design on Patient Affordability - On Demand

Recorded On: 02/21/2024

Copay accumulator adjustment programs are currently a hot legislative topic impacting patient copay assistance for your commercial patients. For Medicare beneficiaries, the passage of the Inflation Reduction Act (IRA) requires substantial changes to the Medicare Part D benefit design. Learn more about what you as a provider can do to help your patients who are impacted by copay accumulator policies as well as confidently communicate the changes to Medicare Part D benefit design for 2024 and 2025 to your Medicare patients.

Learning Objectives:

  1. Review how recent legislation is affecting copay accumulator adjustment policies and commercial patient affordability.
  2. Compare the Medicare Part D benefit designs across 2023, 2024, and 2025.
  3. Describe how future changes in the IRA will benefit the Part B and D patient.

Charles E Collins Jr., MS, MBA

President

Healthcare Stakeholder Solutions™ LLC

Healthcare Stakeholder Solutions is a managed markets consultancy in its 12th year focusing on healthcare delivery disparities. As president, Mr. Collins has over 34 years of career experience in the pharma industry. He has an extensive history of working across both multiple therapeutic areas and all managed market channels, helping to develop customized managed markets solutions. He serves on the Board of Directors as well as a Sr. Fellow to Medonomics, a nonprofit, nonpartisan think tank specializing in health policy, finance, and operations. He also serves as Treasurer and on the Board of Directors of the Specialty Pharmacy Certification Board. He has provided strategic managed markets consultation and tactical implementation to multiple major pharma clients.

In previous roles, he led the managed markets strategic counsel efforts providing insight and execution for commercial, Medicare, Medicaid, long-term care, retail pharmacy chains, and specialty pharmacy providers. Mr. Collins has over 25 years of managed markets expertise in account management, training, marketing, and developing effective pull-through initiatives. He currently speaks on a national basis regarding healthcare delivery disparities at AMCP, NASP, and ASEMBIA. Mr. Collins is a patient advocate and works with non-profit charitable organizations to raise awareness around healthcare trends that impact patient financial assistance programs. In addition, Mr. Collins has published supplements to the Journal of Clinical Outcomes Management® entitled Less is More…A Cost-Minimization Analysis of wilate® as an Effective Treatment Option for von Willebrand Disease and Assessing the Value Proposition of NUWIQ® in the Hemophilia A Market: An Illustrative Model in Cost Avoidance. Recently, Mr. Collins developed a whitepaper entitled “Payor Considerations When Evaluating a Specialty Pharmacy Partner for Rare Diseases and Limited Distribution Products”. Mr. Collins participated in the strategic launch of American Health & Drug Benefits® and, as a founding member of the editorial board, contributed actively for several years.

Mr. Collins graduated with a bachelor's degree in chemistry from Virginia Commonwealth University. Mr. Collins additionally holds a master's degree in clinical chemistry from Old Dominion University and a master's degree of business administration in pharmaceutical marketing from Saint Joseph's University in Philadelphia.

 

No Disclosures to Report

Key:

Complete
Failed
Available
Locked
Impact of Copay Accumulator Legislation and IRA Change to the Medicare Part D Benefit Design on Patient Affordability - On Demand
Recorded 02/21/2024  |  30 minutes
Recorded 02/21/2024  |  30 minutes
Post Webinar Quiz
5 Questions  |  2 attempts  |  80/100 points to pass
5 Questions  |  2 attempts  |  80/100 points to pass
Post Webinar Survey
5 Questions
5 Questions Operations Elevation: Impact of Copay Accumulator Legislation and IRA Changes to the Medicare Part D Benefit Design on Patient Affordability On-Demand Webinar 0.5 CE 0761-9999-24-031-H04-P&T and 05-115-24-005
Required to Claim CE
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available **PHARMACISTS & PHARMACY TECHNICIANS MUST SELECT THE BLUE "CLAIM CREDIT" BUTTON AND ENTER YOUR DOB IN ORDER TO RECEIVE CE CREDIT** ______________________________________________________________________________________________________________________________________________________________________ NHIA adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, panelists, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.